Literature DB >> 27629097

Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.

Hiroki Fujii1, Tetsuya Takahashi1, Tomoya Mukai1,2, Shigeru Tanaka3, Naohisa Hosomi1, Hirofumi Maruyama1, Norio Sakai3, Masayasu Matsumoto1.   

Abstract

Epidemiological studies have suggested a close relationship between cerebral ischemia and Alzheimer's disease (AD). To clarify the pathological association of tau dynamics in both diseases, we performed comprehensive studies on the posttranslational modification of tau in cerebral ischemia and reperfusion (I/R) in rats. The present study suggests that both 4-repeat and 3-repeat tau isoforms are hyperphosphorylated in cerebral I/R, similar to the case in AD. The generation of a 60-kDa Asp421-truncated tau in cerebral I/R preceded the emergence of a 17-kDa 3-repeat tau fragment and a 25-kDa 4-repeat tau fragment. The regional redistribution of tau from the neuropil to neuronal perikarya in our stroke model is thought to share similarity with that occurring in AD. In addition, immunofluorescence staining revealed the formation of axonal varicosities in cerebral I/R. Altered tau distribution may influence microtubule stability, disturbances in axonal transport, and the resulting formation of axonal varicosities. The staining profiles of granules in the ischemic cortex that were immunopositive for RD3, RD4, and AT8 in neuronal perikarya and that were argyrophilic on Gallyas-Braak staining were similar to those in AD. These findings suggest that transient cerebral ischemia shares a common pathology with AD, in the modification of tau protein.

Entities:  

Keywords:  Alzheimer’s disease; cerebral ischemia; cleavage; phosphorylation; tau

Mesh:

Substances:

Year:  2016        PMID: 27629097      PMCID: PMC5531343          DOI: 10.1177/0271678X16668889

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  52 in total

1.  Dephosphorylation of tau during transient forebrain ischemia in the rat.

Authors:  D A Shackelford; R Y Yeh
Journal:  Mol Chem Neuropathol       Date:  1998 Jun-Aug

2.  Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein.

Authors:  Yi Wen; Shaohua Yang; Ran Liu; James W Simpkins
Journal:  Brain Res       Date:  2004-10-01       Impact factor: 3.252

3.  Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.

Authors:  José Luna-Muñoz; Francisco García-Sierra; Viviana Falcón; Ivón Menéndez; Laura Chávez-Macías; Raúl Mena
Journal:  J Alzheimers Dis       Date:  2005-09       Impact factor: 4.472

Review 4.  Neuropathology of Pick's disease.

Authors:  D W Dickson
Journal:  Neurology       Date:  2001-06       Impact factor: 9.910

5.  Poststroke dementia: incidence and relationship to prestroke cognitive decline.

Authors:  H Hénon; I Durieu; D Guerouaou; F Lebert; F Pasquier; D Leys
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

6.  Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury.

Authors:  S Prasad Gabbita; Stephen W Scheff; Renee M Menard; Kelly Roberts; Isabella Fugaccia; Frank P Zemlan
Journal:  J Neurotrauma       Date:  2005-01       Impact factor: 5.269

7.  Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.

Authors:  Angela L Guillozet-Bongaarts; Michael E Cahill; Vincent L Cryns; Matthew R Reynolds; Robert W Berry; Lester I Binder
Journal:  J Neurochem       Date:  2006-04-05       Impact factor: 5.372

8.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2.

Authors:  R L Neve; P Harris; K S Kosik; D M Kurnit; T A Donlon
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

9.  Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.

Authors:  Lisette T Arnaud; Natura Myeku; Maria E Figueiredo-Pereira
Journal:  J Neurochem       Date:  2009-05-03       Impact factor: 5.372

10.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more
  20 in total

Review 1.  Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-06-28       Impact factor: 5.923

2.  Tauopathy in basal ganglia involvement is exacerbated in a subset of patients with Alzheimer's disease: The Hisayama study.

Authors:  Hideomi Hamasaki; Hiroyuki Honda; Satoshi O Suzuki; Masahiro Shijo; Tomoyuki Ohara; Yozo Hatabe; Tsuyoshi Okamoto; Toshiharu Ninomiya; Toru Iwaki
Journal:  Alzheimers Dement (Amst)       Date:  2019-06-06

Review 3.  Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.

Authors:  Marzena Ułamek-Kozioł; Stanisław Jerzy Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

4.  Tau as a potential therapeutic target for ischemic stroke.

Authors:  Xin Chen; Hua Jiang
Journal:  Aging (Albany NY)       Date:  2019-12-16       Impact factor: 5.682

Review 5.  Brain Ischemia as a Prelude to Alzheimer's Disease.

Authors:  Ryszard Pluta; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Front Aging Neurosci       Date:  2021-02-18       Impact factor: 5.702

6.  Heterogeneity in brain distribution of activated microglia and astrocytes in a rat ischemic model of Alzheimer's disease after 2 years of survival.

Authors:  Lidija Radenovic; Marija Nenadic; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar; Pavle R Andjus; Ryszard Pluta
Journal:  Aging (Albany NY)       Date:  2020-06-05       Impact factor: 5.955

Review 7.  Tau Protein Dysfunction after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Janusz Kocki; Jacek Bogucki; Sławomir Januszewski; Anna Bogucka-Kocka; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2019-11-12       Impact factor: 5.682

Review 9.  Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 6.208

Review 10.  Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.

Authors:  Marzena Ułamek-Kozioł; Stanisław J Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.